High-density lipoprotein protects vascular endothelial cells from indoxyl sulfate insults through its antioxidant ability.
Vascular endothelial cell
high-density lipoprotein
indoxyl sulfate
Journal
Cell cycle (Georgetown, Tex.)
ISSN: 1551-4005
Titre abrégé: Cell Cycle
Pays: United States
ID NLM: 101137841
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
pmc-release:
18
01
2025
medline:
22
1
2024
pubmed:
22
12
2023
entrez:
21
12
2023
Statut:
ppublish
Résumé
Chronic kidney disease (CKD) patients have a high risk of cardiovascular disease. Indoxyl sulfate (IS) is a uremic toxin that has been shown to inhibit nitric oxide production and cause cell senescence by inducing oxidative stress. High-density lipoprotein (HDL) has a protective effect on the cardiovascular system; however, its impacts on IS-damaged endothelial cells are still unknown. This study aimed to explore the effects of exogenous supplement of HDL on vascular endothelial cells in a uremia-mimic environment. Tube formation, migration, adhesion, and senescence assays were used to evaluate the cell function of human aortic endothelial cells (HAECs). Reactive oxygen species generation was measured by using Amplex red assay. L-NAME and MCI186 were used as a nitric oxide synthase inhibitor and a free radical scavenger, respectively. HDL exerted anti-inflammatory and antioxidant effects via HIF-1α/HO-1 activation and IL-1β/TNF-α/IL-6 inhibition in IS-stimulated HAECs. HDL improved angiogenesis ability through upregulating Akt/eNOS/VEGF/SDF-1 in IS-stimulated HAECs. HDL decreased endothelial adhesiveness via downregulating VCAM-1 and ICAM-1 in IS-stimulated HAECs. Furthermore, HDL reduced cellular senescence via upregulating SIRT1 and downregulating p53 in IS-stimulated HAECs. Importantly, the above beneficial effects of HDL were mainly due to its antioxidant ability. In conclusion, HDL exerted a comprehensive protective effect on vascular endothelial cells against damage from IS through its antioxidant ability. The results of this study might provide a theoretical basis for potential HDL supplementation in CKD patients with endothelial damage.
Identifiants
pubmed: 38129288
doi: 10.1080/15384101.2023.2296184
pmc: PMC10802207
doi:
Substances chimiques
Antioxidants
0
Lipoproteins, HDL
0
Indican
N187WK1Y1J
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2409-2423Références
Circulation. 2004 Jun 15;109(23 Suppl 1):III8-14
pubmed: 15198960
Kidney Int. 2004 Feb;65(2):442-51
pubmed: 14717914
J Biol Chem. 2001 Sep 14;276(37):34480-5
pubmed: 11432865
Thromb Haemost. 2014 Nov;112(5):1024-35
pubmed: 25056722
J Biol Chem. 2010 Feb 12;285(7):4387-97
pubmed: 20018878
J Ren Nutr. 2012 Jan;22(1):86-9
pubmed: 22200421
Cardiovasc Res. 2014 Jan 1;101(1):145-54
pubmed: 24130189
Clin J Am Soc Nephrol. 2011 Jan;6(1):30-9
pubmed: 20876676
Diabetologia. 2008 Jun;51(6):1081-4
pubmed: 18389214
Arch Toxicol. 2016 Nov;90(11):2779-2792
pubmed: 26659566
Am J Kidney Dis. 1998 Nov;32(5 Suppl 3):S112-9
pubmed: 9820470
Atherosclerosis. 2015 Nov;243(1):248-56
pubmed: 26408929
Int J Mol Sci. 2020 Jan 17;21(2):
pubmed: 31963445
J Clin Lab Anal. 2011;25(3):191-7
pubmed: 21567467
J Clin Invest. 2008 Nov;118(11):3701-13
pubmed: 18924609
Heart Asia. 2016 Nov 7;8(2):56-61
pubmed: 27933104
Circulation. 2005 Mar 29;111(12):1543-50
pubmed: 15781735
Front Physiol. 2017 Sep 08;8:666
pubmed: 28951723
Circulation. 2004 Nov 23;110(21):3355-9
pubmed: 15545521
Int J Biochem Cell Biol. 2003 Feb;35(2):168-82
pubmed: 12479867
Toxins (Basel). 2018 Mar 15;10(3):
pubmed: 29543732
Pharmacol Res. 2020 Jan;151:104509
pubmed: 31678640
Eur J Endocrinol. 2013 Dec 21;170(2):173-80
pubmed: 24165018
J Clin Invest. 2011 Jul;121(7):2693-708
pubmed: 21701070
Diabetologia. 2000 Mar;43(3):312-20
pubmed: 10768092
J Atheroscler Thromb. 2014;21(9):904-16
pubmed: 24727683
J Thromb Haemost. 2007 Jun;5(6):1302-8
pubmed: 17403109
Cardiovasc Res. 2008 May 1;78(2):349-55
pubmed: 18056764
J Atheroscler Thromb. 2016 Aug 1;23(8):960-75
pubmed: 26860885
Biochem Biophys Res Commun. 1997 Sep 8;238(1):61-5
pubmed: 9299452
Arterioscler Thromb Vasc Biol. 2012 Oct;32(10):2405-17
pubmed: 22904272
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):151-5
pubmed: 19679832
PLoS One. 2013;8(1):e53106
pubmed: 23382833
Kidney Int. 2016 Mar;89(3):574-85
pubmed: 26880454
Eur Heart J. 2017 May 21;38(20):1597-1607
pubmed: 28379378
J Lipid Res. 2023 Jun;64(6):100381
pubmed: 37100172
Angiogenesis. 2013 Jul;16(3):609-24
pubmed: 23408148
Clin Invest Med. 2013 Feb 01;36(1):E42-9
pubmed: 23374599
Kidney Int Suppl. 1997 Nov;62:S23-8
pubmed: 9350673
Nat Rev Cardiol. 2016 Jan;13(1):48-60
pubmed: 26323267
J Biol Chem. 2003 Mar 14;278(11):9142-9
pubmed: 12511559
Toxins (Basel). 2014 Jun 04;6(6):1742-60
pubmed: 24902077
EBioMedicine. 2019 May;43:32-42
pubmed: 31000420
J Am Soc Nephrol. 2012 Jul;23(7):1258-70
pubmed: 22626821
Int J Med Sci. 2018 Jun 14;15(10):978-985
pubmed: 30013438
Am J Nephrol. 2009;29(6):551-7
pubmed: 19129694
Int J Cardiol. 2015 Nov 15;199:204-12
pubmed: 26204569
Am J Nephrol. 2007;27(1):30-5
pubmed: 17215572
Clin J Am Soc Nephrol. 2009 Oct;4(10):1551-8
pubmed: 19696217
Toxins (Basel). 2019 Oct 11;11(10):
pubmed: 31614554
J Am Soc Nephrol. 2018 May;29(5):1356-1371
pubmed: 29472417
J Am Soc Nephrol. 2014 Nov;25(11):2658-68
pubmed: 24854267
Toxins (Basel). 2020 Nov 02;12(11):
pubmed: 33147880
J Cell Biol. 2015 Mar 16;208(6):821-38
pubmed: 25753039
Lipids Health Dis. 2017 Oct 30;16(1):207
pubmed: 29084567
J Am Soc Nephrol. 2014 May;25(5):1073-82
pubmed: 24610925